CompletedPhase 2

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

NCT01342484

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

1218.56.01006 Boehringer Ingelheim Investigational Site

San Antonio, Texas, United States

+24 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2011-04
Enrollment: 40 participants
Sponsor: Boehringer Ingelheim
Purpose: treatment

Locations (25)

1218.56.01006 Boehringer Ingelheim Investigational SiteSan Antonio, Texas, United States
1218.56.01004 Boehringer Ingelheim Investigational SiteNorfolk, Virginia, United States
1218.56.11001 Boehringer Ingelheim Investigational SiteMontreal, Quebec, Canada
1218.56.33003 Boehringer Ingelheim Investigational SiteFort de France Cedex, France
1218.56.33006 Boehringer Ingelheim Investigational SiteRouen, France
1218.56.50202 Boehringer Ingelheim Investigational SiteGuatemala City, Guatemala
1218.56.50203 Boehringer Ingelheim Investigational SiteGuatemala City, Guatemala
1218.56.39005 Boehringer Ingelheim Investigational SiteFlorence, Italy
1218.56.52008 Boehringer Ingelheim Investigational SiteChihuahua City, Mexico
1218.56.52002 Boehringer Ingelheim Investigational SiteGuadalajara, Mexico
1218.56.52001 Boehringer Ingelheim Investigational SiteLeón, Mexico
1218.56.52003 Boehringer Ingelheim Investigational SiteMonterrey, Mexico
1218.56.52004 Boehringer Ingelheim Investigational SiteOaxaca City, Mexico
1218.56.48002 Boehringer Ingelheim Investigational SiteGdansk, Poland
1218.56.48001 Boehringer Ingelheim Investigational SiteGliwice, Poland
1218.56.48004 Boehringer Ingelheim Investigational SiteWarsaw, Poland
1218.56.48003 Boehringer Ingelheim Investigational SiteWroclaw, Poland
1218.56.70001 Boehringer Ingelheim Investigational SiteMoscow, Russia
1218.56.70003 Boehringer Ingelheim Investigational SiteSaratov, Russia
1218.56.70004 Boehringer Ingelheim Investigational SiteUfa, Russia
1218.56.70006 Boehringer Ingelheim Investigational SiteYekaterinburg, Russia
1218.56.82005 Boehringer Ingelheim Investigational SiteBusan, South Korea
1218.56.82001 Boehringer Ingelheim Investigational SiteSeoul, South Korea
1218.56.82002 Boehringer Ingelheim Investigational SiteSeoul, South Korea
1218.56.82003 Boehringer Ingelheim Investigational SiteSuwon, South Korea